Yunnan Jianfeng Revises Safety and Environmental Protection System
Release time:
2020-12-22
Yunnan Jianfeng Revises Safety and Environmental Protection System
In November, Yunnan Jianfeng Cement Company made a comprehensive and systematic revision of the management system related to employee health and safety, environmental protection performance, etc.
The revised relevant systems mainly include "Detailed Rules for Health, Safety and Environmental Protection Performance Evaluation of Middle-level Managers in 2020", "Detailed Rules for Health, Safety and Environmental Protection Performance Evaluation of Employees in 2020", "Yunnan Peak Health, Safety and Environmental Protection Management System" and "Employee Performance Card", covering the job responsibilities of management team members, middle-level managers, departments and offices, health, safety and environmental protection performance, etc.
In order to make the revised system more targeted and practical, Yunnan Jianfeng takes the relevant management system of the group company as the core, refers to the experience of brother companies, and strives to be comprehensive in content, clear in responsibilities, and clear in rewards and punishments according to the actual situation of the company, To further standardize the performance management of corporate health, safety and environmental protection. To this end, Yunnan Jianfeng also organized the management team and managers of relevant departments to hold special meetings to systematically sort out the deficiencies in the implementation of these systems, analyze the reasons, and put forward suggestions for revision.
The revised series of management systems have been officially implemented since December 1. Zhou Jiping, general manager of Yunnan Jianfeng, said that the purpose of further systematic revision of the safety and environmental protection system is to strengthen key control in site management, supervision of related parties, and environmental protection foundation, so as to maintain the normalization of health, safety and environmental protection work. He hopes that the relevant responsible persons and team leaders of Yunnan Jianfeng health, safety and environmental protection will further strengthen daily supervision and management, guide all employees to further improve their awareness of health, safety and environmental protection, and enhance their sense of responsibility. to ensure the effective implementation of the health, safety and environmental protection performance management system, so as to raise the level of enterprise health, safety and environmental protection management to a higher level. (Liu Fengbin)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31